Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances
Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances ICD-10-CM Code range T36-T50
The ICD-10 code range for Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances T36-T50 is medical classification list by the World Health Organization (WHO).
ICD-10 Code range (T36-T50), Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances contains ICD-10 codes for Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system, Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action, Poisoning by, adverse effect of and underdosing of calcium-channel blockers, Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified, Poisoning by, adverse effect of and underdosing of coronary vasodilators, Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors, Poisoning by, adverse effect of and underdosing of other antihypertensive drugs, Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs, Poisoning by, adverse effect of and underdosing of peripheral vasodilators, Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents, Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
T36-T50
Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances
- T46.0X1A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
- T46.0X1D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
- T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
- T46.0X1A -
- T46.0X2A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
- T46.0X2D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
- T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
- T46.0X2A -
- T46.0X3A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
- T46.0X3D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
- T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
- T46.0X3A -
- T46.0X4A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
- T46.0X4D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
- T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
- T46.0X4A -
- T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
- T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
- T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
- T46.0X5A -
- T46.4X1A - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
- T46.4X1D - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
- T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
- T46.4X1A -
- T46.4X2A - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
- T46.4X2D - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
- T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
- T46.4X2A -
- T46.6X1A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
- T46.6X1D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
- T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
- T46.6X1A -
- T46.6X2A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
- T46.6X2D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
- T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
- T46.6X2A -
- T46.6X4A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
- T46.6X4D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
- T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
- T46.6X4A -
- T46.8X1A - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
- T46.8X1D - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
- T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
- T46.8X1A -
- T46.8X2A - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
- T46.8X2D - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
- T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
- T46.8X2A -
- T46.8X4A - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
- T46.8X4D - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
- T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
- T46.8X4A -
- T46.901A - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
- T46.901D - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
- T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
- T46.901A -
- T46.902A - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
- T46.902D - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
- T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
- T46.902A -
- T46.903A - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
- T46.903D - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
- T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
- T46.903A -
- T46.904A - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
- T46.904D - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
- T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
- T46.904A -
- T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.905A -
- T46.906A - Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
- T46.906D - Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
- T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
- T46.906A -
- T46.991A - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
- T46.991D - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
- T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
- T46.991A -
- T46.992A - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
- T46.992D - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
- T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
- T46.992A -
- T46.993A - Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
- T46.993D - Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
- T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
- T46.993A -
- T46.994A - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
- T46.994D - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
- T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
- T46.994A -
- T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
- T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela
- T46.995A -
- T46.996A - Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
- T46.996D - Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
- T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela
- T46.996A -